Molly Martell brings almost 30 years of healthcare experience - half of which is in clinical diagnostics. Ms. Martell has worked on Next Generation Sequencing and PCR based assays in infectious disease, cancer and transplantation, including the successful commercialization and launch of 8 laboratory developed tests for the US and global markets. Ms. Martell advises and provides consulting services to companies entering the US and Japan markets, providing insight on strategic partners and commercialization.